Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynamin 1 pseudogene 17 (DNM1P17) is a genomic region designated as a pseudogene related to the dynamin 1 (DNM1) gene family[8]. Pseudogenes such as DNM1P17 do not encode functional proteins and are generally considered non-functional relics of gene duplication or retrotransposition events. As such, DNM1P17 is not a therapeutic target, does not participate in biological pathways, and currently has no known roles in disease, biomarker development, or pharmacological intervention[8]. If you require information on the functional gene/protein related to dynamin 1 (DNM1), which is involved in vesicle trafficking and neurological disease, clarify your query to "dynamin 1" or "DNM1" for relevant details on that functional target[4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynamin 1 pseudogene 17 (DNM1P17).